missing translation for 'onlineSavingsMsg'
Learn More

CD35 Antibody (HB-8592) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody

€ 250.00 - € 642.60

Specifications

Antigen CD35
Clone HB-8592
Concentration 1 mg/mL
Applications Flow Cytometry
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18619368
View Documents
Novus Biologicals
NBP3-09019-0.025mg
0.025 mg
€ 250.00
25µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18610169
View Documents
Novus Biologicals
NBP3-09019-0.2mg
0.2 mg
ONLINE EXCLUSIVE PRICE
€ 680.00
€ 642.60 / 0.20mg
Save € 37.40
5% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CD35 Monoclonal antibody specifically detects CD35 in Human samples. It is validated for Flow Cytometry
Specifications

Specifications

CD35
1 mg/mL
Monoclonal
Purified
RUO
Human
complement component (3b/4b) receptor 1 (Knops blood group), KN
Animals were immunized with purified CR1 from human erythrocytes. Spleen cells were fused with P3X63Ag8.653 myeloma cells.
Primary
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
HB-8592
Flow Cytometry
Unconjugated
Mouse
Immunology
PBS
1378
IgG1 κ
Protein A purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.